Johnson & Johnson Is Close to Deal for Pfizer Unit - New York Times
Johnson and Johnson would acquire the maker of brands like Listerine and Sudafed for more than $16 billion.
J.& J. Loses Injunction Bid - New York Times Help Mr. Reach solve the mystery - AdJab Executive Sentenced in Pornography Case - New York Times Hospital Giant HCA Is Close to a Record Buyout - New York Times LA Times weighs in on decision to sell front-page ads - AdJab Court Invalidates a Patent That Pfizer Holds for Lipitor - New York Times Dynegy in Deal to Raise Generating Capacity by 69% - New York Times